Your browser doesn't support javascript.
loading
Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
Rensing-Ehl, Anne; Völkl, Simon; Speckmann, Carsten; Lorenz, Myriam Ricarda; Ritter, Julia; Janda, Ales; Abinun, Mario; Pircher, Hanspeter; Bengsch, Bertram; Thimme, Robert; Fuchs, Ilka; Ammann, Sandra; Allgäuer, Andrea; Kentouche, Karim; Cant, Andrew; Hambleton, Sophie; Bettoni da Cunha, Claudia; Huetker, Sebastian; Kühnle, Ingrid; Pekrun, Arnulf; Seidel, Markus G; Hummel, Michael; Mackensen, Andreas; Schwarz, Klaus; Ehl, Stephan.
Afiliación
  • Rensing-Ehl A; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany;
  • Völkl S; Department of Internal Medicine 5, Haematology and Oncology, University Hospital Erlangen, Erlangen, Germany;
  • Speckmann C; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany; Center for Paediatrics and Adolescent Medicine, University Medical Center, University of Freiburg, Freiburg, Germany;
  • Lorenz MR; Institute for Transfusion Medicine, University of Ulm, Ulm, Germany;
  • Ritter J; Institute of Pathology, Charité - University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany;
  • Janda A; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany; Center for Paediatrics and Adolescent Medicine, University Medical Center, University of Freiburg, Freiburg, Germany;
  • Abinun M; Department of Paediatric Immunology, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom; Institute of Cellular Immunology, Newcastle University, Newcastle upon Tyne, United Kingdom;
  • Pircher H; Institute of Immunology, Department of Medicine Microbiology and Hygiene, and.
  • Bengsch B; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany; Department of Internal Medicine II, University Medical Center Freiburg, Freiburg, Germany;
  • Thimme R; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany; Department of Internal Medicine II, University Medical Center Freiburg, Freiburg, Germany;
  • Fuchs I; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany;
  • Ammann S; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany;
  • Allgäuer A; Department of Internal Medicine 5, Haematology and Oncology, University Hospital Erlangen, Erlangen, Germany;
  • Kentouche K; Department of Paediatrics, Jena University Hospital, Jena, Germany;
  • Cant A; Department of Paediatric Immunology, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom; Institute of Cellular Immunology, Newcastle University, Newcastle upon Tyne, United Kingdom;
  • Hambleton S; Department of Paediatric Immunology, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom; Institute of Cellular Immunology, Newcastle University, Newcastle upon Tyne, United Kingdom;
  • Bettoni da Cunha C; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hanover Hannover, Germany;
  • Huetker S; Division of Pediatric Haematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Göttingen, Göttingen, Germany;
  • Kühnle I; Division of Pediatric Haematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Göttingen, Göttingen, Germany;
  • Pekrun A; Department of Paediatric Haematology/Oncology, University Medical Center Bremen, Bremen, Germany.
  • Seidel MG; Paediatric Haematology-Oncology, Medical University of Graz, Graz, Austria; and.
  • Hummel M; Institute of Pathology, Charité - University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany;
  • Mackensen A; Department of Internal Medicine 5, Haematology and Oncology, University Hospital Erlangen, Erlangen, Germany;
  • Schwarz K; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany; Institute for Transfusion Medicine, University of Ulm, Ulm, Germany; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service, Ulm, Germany
  • Ehl S; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany; Center for Paediatrics and Adolescent Medicine, University Medical Center, University of Freiburg, Freiburg, Germany;
Blood ; 124(6): 851-60, 2014 Aug 07.
Article en En | MEDLINE | ID: mdl-24894771
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Subgrupos de Linfocitos T / Linfocitos T CD8-positivos / Receptor fas / Síndrome Linfoproliferativo Autoinmune Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans Idioma: En Revista: Blood Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Subgrupos de Linfocitos T / Linfocitos T CD8-positivos / Receptor fas / Síndrome Linfoproliferativo Autoinmune Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Humans Idioma: En Revista: Blood Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos